Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Neurobiol Dis. 2016 Apr 9;93:1–11. doi: 10.1016/j.nbd.2016.03.022

Figure 1. Loss of full length Par3 in human AD brains.

Figure 1

(a) Lysates from the temporal lobes of AD patients or healthy age-matched controls were analyzed by Western blotting.

(b) Quantification of levels of the full length, 180KD isoform of Par3. Data were expressed as Mean ± SEM with Student's t test: N=7; *p<0.05.